You just read:

PEGPH20 Selected For Inclusion In Groundbreaking Clinical Trial Initiative Designed To Transform Outcomes For Pancreatic Cancer Patients

News provided by

Halozyme Therapeutics, Inc.

Oct 04, 2016, 06:15 ET